Impurity deficiencies in submissions are remarkably consistent. Subathra Ramamoorthy, Veranova, explains how to catch them before agency filing.
News|Articles|August 26, 2021
- Pharmaceutical Technology's In the Lab eNewsletter, September 2021
- Volume 16
- Issue 09
Promega to Showcase Applications of Bioluminescent Research Tools at Global Seminar Series
Author(s)Pharmaceutical Technology Editors
Promega will demonstrate applications of bioluminescence tools at Discover Glo 2021.
Advertisement
Promega Corporation announced that it will showcase various applications of bioluminescence research tools at their Discover Glo 2021 conference, a virtual event which will be held Sept. 13–16, 2021.
The aim of the conference is to advance understanding in key therapeutic areas, such as targeted protein degradation and kinase biology. Each day will feature discussions focusing on a topic surrounding luciferase technologies.
These daily topics include:
- Bioluminescence: Past, Present, Future (Sept. 13)
- Applications of CRISPR Knock-in Tagging for Studying Endogenous Protein Dynamics (Sept. 14)
- Understanding Kinase Target Engagement in Live Cells (Sept. 15)
- Advances in Targeted Protein Degradation (Sept. 16)
Prominent speakers from various related fields will be in attendance. For a full list of these individuals, the company press release can be found
Source:
Articles in this issue
about 5 years ago
Enhanced Bioavailability of Acalabrutinib ASD Tablets In-Vivoabout 5 years ago
Biotium’s New Staining Kit Aims to Optimize Exosome Detectionabout 5 years ago
Next-Gen Automation Lab Aims to Speed Up Drug Discovery Processabout 5 years ago
BioAgilytix Acquires Australian-Based CRO 360biolabsabout 5 years ago
Todos Medical to Launch New Antibody Blood Test for COVID-19about 5 years ago
NIH Scientists Develop Faster COVID-19 Testover 5 years ago
FDA Issues NIR GuidanceAdvertisement
Related to this article
Subathra Ramamoorthy, Veranova, on how forced degradation and trace impurity profiling in potent APIs shape regulator-ready analytical methods.
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF in Tarrytown, spoke with PharmTech at AAPS PharmSci 360 about formulation and characterization challenges for amorphous solid dispersions.
FDA draft guidance on individualized genome editing lets BLAs add patient-specific variants without new trials, shifting evidence to CMC assay data.
Pauline van der Wijst-Janssen, PhD, of DFE Pharma, won the CPHI Pharma Award for Future Leader. In this interview with PharmTech, she provides advice for scientists looking to advance to leadership roles.
Coverage from AAPS PharmSci 360 and CPHI Milan featured discussion about impurities, devices, and supply resilience. This week also included topics such as AI accountability, oral peptides, and new licensing deals.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
2
Meeting Tomorrow's Market Requirements: Vetter's Perspective on the Future of Fill & Finish
3
Why Drug Shortages Average 5+ Years: PharmTech Explained
4
ADCs, Degraders, Agonists: 4 Deals CMC Teams Should Track
5